Lanean...
Combinatorial approach to cancer immunotherapy: strength in numbers
Immune‐checkpoint blockade therapy with antibodies targeting CTLA‐4 and PD‐1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies. However, not all patients respond to immune‐checkpoint inhibitors. Extensive preclinica...
Gorde:
| Argitaratua izan da: | J Leukoc Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608090/ https://ncbi.nlm.nih.gov/pubmed/27256570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5RI0116-013RR |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|